Clinical Trials Browser

Unknown × Leukemia, Myeloid, Acute × Bortezomib × Clear all

NCT05982756 2023-08-09

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00510939 2009-08-14

HEMOS AML 0106

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute